SARS-CoV-2 infection can lead to long-lasting, recurring, or new symptoms occurring after the acute phase of COVID-19, known as post–COVID-19 condition (PCC).1 Given PCC’s effect on quality of life, income, and health care expenses,2 assessing its long-term prevalence is crucial. Recent findings highlight the contribution of olfactory dysfunction (OD) and gustatory dysfunction (GD) to the manifestation of PCCs.1,3 No data exist regarding psychophysical assessment of OD and GD 3 years after COVID-19, to our knowledge. In this study, we estimate the 3-year prevalence of measured OD and GD associated with SARS-CoV-2 infection